Financials

Discussions Technicals Seasonals

6986 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

HeXun Biosciences Co., Ltd. engages in the research and development of stem cell and new drug development. Its production line includes various core technologies required by the cell therapy industry to provide CMO (contracted production services) and CDMO (commissioned development and manufacturing services) and testing services. The company was founded by Cheng Han Wen on June 12, 2019 and is headquartered in Taoyuan, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

6986 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company